TrialBMC cancer2020

Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab.

Sergey M Alexeev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.